Concepedia

Ashok Bhandari

AB

3

Publications

74

Citations

3

H-Index

2015

Active since

Affiliations

Protagonist Therapeutics (United States)(Current)

The University of Queensland

Ashok Bhandari is an author at Protagonist Therapeutics (United States) specializing in allergy, chronic inflammation, and inflammatory arthritis.

Top concepts

Publications per year

2015–2024

3

Publications

3

Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo

Sheila Ranganath, Ashok Bhandari, Nicole Avitahl-Curtis et al. · PLoS ONE · 2015 · 42 citations · Full text

, , +17

JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans

Anne M. Fourie, Xiaoli Cheng, Leon Chang et al. · Scientific Reports · 2024 · 20 citations · Full text

Clustering of disulfide-rich peptides provides scaffolds for hit discovery by phage display: application to interleukin-23

David T. Barkan, Xiaoli Cheng, Herodion Celino et al. · BMC Bioinformatics · 2016 · 12 citations · Full text

Rows per page

1–3 of 3